Additionally, FACS analysis of CD45+Col1+ cells (Fig. 4E, F) showed significantly increased numbers of circulating fibrocytes in PBMCs isolated from patients with lung cancer compared with healthy control samples. This evidence concerns the gene PTPRC and lung carcinoma.